XBRYK Trademark

Trademark Overview


On Monday, January 22, 2024, a trademark application was filed for XBRYK with the United States Patent and Trademark Office. The USPTO has given the XBRYK trademark a serial number of 79390822. The federal status of this trademark filing is REGISTERED as of Tuesday, February 25, 2025. This trademark is owned by SAMSUNG BIOEPIS CO., LTD.. The XBRYK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; dietary supplements; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; human vaccine preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of bone fractures; phar...
xbryk

General Information


Serial Number79390822
Word MarkXBRYK
Filing DateMonday, January 22, 2024
Status700 - REGISTERED
Status DateTuesday, February 25, 2025
Registration Number7699874
Registration DateTuesday, February 25, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; dietary supplements; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; human vaccine preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; preparations for treatment of cancer; preparations for treatment of tumour diseases; preparations for treatment of multiple myeloma; pharmaceutical preparations for the treatment of skeletal diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of solid cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 13, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameSAMSUNG BIOEPIS CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Thursday, March 7, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, March 13, 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, March 20, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 24, 2024APPLICATION FILING RECEIPT MAILED
Friday, June 7, 2024ASSIGNED TO EXAMINER
Monday, June 17, 2024NON-FINAL ACTION WRITTEN
Tuesday, June 18, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 8, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, July 8, 2024REFUSAL PROCESSED BY MPU
Sunday, July 28, 2024REFUSAL PROCESSED BY IB
Friday, December 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 13, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 14, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 1, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 7, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 25, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, May 26, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, August 6, 2025NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, February 25, 2025REGISTERED-PRINCIPAL REGISTER
Wednesday, September 3, 2025FINAL DISPOSITION PROCESSED
Wednesday, September 3, 2025FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 19, 2025FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 22, 2025NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, August 6, 2025NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB